• Share
  • Email
  • Embed
  • Like
  • Save
  • Private Content
Dengue   pipeline review, h1 2014
 

Dengue pipeline review, h1 2014

on

  • 52 views

This report provides comprehensive information on the therapeutic development for Dengue, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of ...

This report provides comprehensive information on the therapeutic development for Dengue, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.

Statistics

Views

Total Views
52
Views on SlideShare
52
Embed Views
0

Actions

Likes
0
Downloads
0
Comments
0

0 Embeds 0

No embeds

Accessibility

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    Dengue   pipeline review, h1 2014 Dengue pipeline review, h1 2014 Document Transcript

    • Dengue - Pipeline Review, H1 2014 This report provides comprehensive information on the therapeutic development for Dengue, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Dengue and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Scope The report provides a snapshot of the global therapeutic landscape of Dengue The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities The report reviews key players involved in the therapeutics development for Dengue and enlists all their major and minor projects The report summarizes all the dormant and discontinued pipeline projects A review of the Dengue products under development by companies and universities/research institutes based on information derived from company and industry-specific sources Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages A detailed assessment of monotherapy and combination therapy pipeline projects Coverage of the Dengue pipeline on the basis of target, MoA, route of administration and molecule type Latest news and deals relating related to pipeline products Reasons to buy Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage Develop strategic initiatives by understanding the focus areas of leading companies Identify and understand important and diverse types of therapeutics under development for Dengue Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline Devise corrective measures for pipeline projects by understanding Dengue pipeline depth and focus of Indication therapeutics Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline table Of Contents table Of Contents 2 list Of Tables 6 list Of Figures 7 introduction 8 global Markets Direct Report Coverage 8 dengue Overview 9 therapeutics Development 10 pipeline Products For Dengue Overview 10 pipeline Products For Dengue Comparative Analysis 11 dengue Therapeutics Under Development By Companies 12 dengue Therapeutics Under Investigation By Universities/institutes 16 dengue Pipeline Products Glance 18 late Stage Products 18 clinical Stage Products 19 early Stage Products 20 unknown Stage Products 21 dengue Products Under Development By Companies 22 dengue Products Under Investigation By Universities/institutes 25 dengue Companies Involved In Therapeutics Development 26 glaxosmithkline Plc 26 genvec, Inc. 27 merck & Co., Inc. 28 takeda Pharmaceutical Company Limited 29 fit Biotech Oyj 30 biological E. Limited 31 biotron Limited 32 sarepta Therapeutics, Inc. 33 medivir Ab 34 nanoviricides, Inc. 35 siga Technologies, Inc. 36 panacea Biotec Limited 37 bharat Biotech International Limited 38 protein Potential, Llc 39 Dengue - Pipeline Review, H1 2014
    • technovax, Inc. 40 macrogenics, Inc. 41 ptc Therapeutics, Inc. 42 chimerix, Inc. 43 immunotope, Inc. 44 immunovaccine, Inc. 45 vaxinnate Corporation 46 janssen Pharmaceuticals, Inc. 47 cocrystal Discovery, Inc. 48 paxvax 49 altravax Inc. 50 oneness Biotech Co., Ltd. 51 arbovax, Inc. 52 sanofi Pasteur Sa 53 themis Bioscience Gmbh 54 agilvax, Inc. 55 humabs Biomed Sa 56 codagenix, Inc. 57 dengue Therapeutics Assessment 58 assessment By Monotherapy Products 58 assessment By Combination Products 59 assessment By Target 60 assessment By Mechanism Of Action 63 assessment By Route Of Administration 66 assessment By Molecule Type 68 drug Profiles 71 dengue Vaccine - Drug Profile 71 denvax - Drug Profile 73 tetravax-dv Vaccine-admixture Tv003 - Drug Profile 75 attenuated Tetravalent Lyophilized Dengue Vaccine - Drug Profile 77 celgosivir Hydrochloride - Drug Profile 78 tetravax-dv Vaccine-admixture 1 - Drug Profile 79 tetravax-dv Vaccine-admixture 2 - Drug Profile 80 tetravax-dv Vaccine-admixture Tv005 - Drug Profile 81 v-180 - Drug Profile 83 dengue Vaccine - Drug Profile 84 denv-1 Piv - Drug Profile 86 st-148 - Drug Profile 87 denguecide - Drug Profile 88 tvx-005 - Drug Profile 89 dengue Vaccine - Drug Profile 90 avi-6006 - Drug Profile 91 dengue Vaccine - Drug Profile 92 dv2g460p - Drug Profile 94 squalamine Lactate - Drug Profile 96 st-610 - Drug Profile 97 dengue Fever Vaccine - Drug Profile 98 dengue Tetravalent Vaccine - Drug Profile 99 vaccine For Dengue - Drug Profile 100 dengue Vaccine - Drug Profile 101 clec5a Mab - Drug Profile 102 dengue Virus Vaccines - Drug Profile 103 dengue Virus Vacine - Drug Profile 104 dengue Vaccine - Drug Profile 105 greden/v1-4 - Drug Profile 106 subunit Vaccine For Dengue - Drug Profile 107 dengue Vaccine - Drug Profile 108 den-2-je Virus Chimeric Plasmid Vaccine - Drug Profile 109 chimeric Live-attenuated Dengue Vaccine - Drug Profile 110 denv-1/2 Prm + E Chimeric Vaccine - Drug Profile 111 vaccine For Dengue - Drug Profile 112 small Molecules To Inhibit Furin For Dengue - Drug Profile 113 dv-2-deltagvii - Drug Profile 114 dv-2-deltalig - Drug Profile 115 mult. Mabs/darts - Drug Profile 116 small Molecule For Dengue - Drug Profile 117 vaccine For Dengue Fever - Drug Profile 118 small Molecule For Viral Infections - Drug Profile 119 Dengue - Pipeline Review, H1 2014
    • small Molecule To Inhibit Ns3 Protease For Dengue - Drug Profile 120 viral Pmo-x - Drug Profile 121 small Molecule For Dengue - Drug Profile 122 lcta-949 - Drug Profile 123 ditu - Drug Profile 124 bg-323 - Drug Profile 125 small Moleucles To Activate Ampk For Dengue - Drug Profile 126 small Molecules To Inhhibit Serine Protease For Viral Infections - Drug Profile 127 subunit Vaccine For Dengue Fever - Drug Profile 128 monoclonal Antibody To Inhibit Prm And E Proteins For Dengue - Drug Profile 129 pav-866 - Drug Profile 130 mab Against Dengue - Drug Profile 131 vaccine For Dengue Fever - Drug Profile 132 small Molecule Inhibitors Of Ns3 Protease For Dengue And West Nile Virus Infections - Drug Profile 133 protease Inhibitors - Drug Profile 134 etx-101 - Drug Profile 135 monoclonal Antibodies For Dengue Fever - Drug Profile 136 small Molecule For Dengue Virus Infections - Drug Profile 137 vaccine For Dengue Virus Infections - Drug Profile 138 recombinant Chimeric Recombinant Tetravalent Dengue Vaccine - Drug Profile 139 recombinant Tetravalent Dengue Vaccine - Drug Profile 140 dengue Recent Pipeline Updates 141 dengue Dormant Projects 147 dengue Discontinued Products 148 dengue Product Development Milestones 149 featured News & Press Releases 149 appendix 159 methodology 159 coverage 159 secondary Research 159 primary Research 159 expert Panel Validation 159 contact Us 160 disclaimer 160 ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price. Contact: M/s Sheela, 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-997-4948 Email: sales@researchmoz.us Website: http://www.researchmoz.us/ Dengue - Pipeline Review, H1 2014